Prenetics Global Limited (PRE) Stock: $48M Funding Ignites Bitcoin Expansion and Supplement Boom

Genetic testing giant makes bold crypto pivot with massive capital injection

The Funding Fuel

$48 million war chest transforms Prenetics from DNA specialist to digital asset contender. Investors betting big on the company's sudden Bitcoin ambitions and supplement division growth.

Bitcoin Bandwagon

Traditional healthcare meets cryptocurrency in unexpected corporate marriage. Market watches closely as established biotech player dives headfirst into volatile crypto waters.

Supplement Surge

While Bitcoin grabs headlines, the supplement division quietly builds momentum. Dual-track strategy aims to capture both digital and physical wellness markets simultaneously.

Another day, another company discovering that adding 'Bitcoin' to the press release gets more attention than actual revenue projections. The market never learns—but maybe this time will be different?

TLDR

• Prenetics secures $48M to scale IM8 and accelerate Bitcoin accumulation.
• IM8 hits $100M ARR in under a year—targeting $200M by 2026.
• New capital powers IM8’s global push and product innovation drive.
• Bitcoin holdings reach 275 BTC as Prenetics builds $1B treasury goal.
• Star investors back Prenetics’ vision blending wellness and Web3 growth

Prenetics Global Limited (NASDAQ: PRE) closed sharply lower at $13.08 on October 27, down 21.96%.

Prenetics Global Limited, PRE

The company raised $48 million through an oversubscribed public offering involving shares, pre-funded warrants, and a double warrant structure. The funding aims to support its fast-growing supplement brand IM8 and accelerate its Bitcoin accumulation strategy.

IM8 Supplement Brand Rapidly Expands Revenue and Global Reach

Prenetics launched IM8 just 11 months ago and has already achieved $100 million in annual recurring revenue. The supplement brand, co-founded with global football icon David Beckham, is on track to generate $160–$200 million in 2026. This aggressive growth signals strong consumer demand and market traction across key regions.

The capital raise will allow IM8 to enter new markets and expand its distribution channels globally. The brand leverages celebrity partnerships and cultural influence to boost its presence and appeal to wellness-conscious consumers. Its unique positioning in the $704 billion global supplements market could offer continued upside through strategic product innovation.

The company plans to divest other non-core business units to focus exclusively on IM8 and its digital health ecosystem. This strategy ensures all resources target growth opportunities with the highest potential return. Management believes this focus will enhance shareholder value in the long term.

Bitcoin Treasury Strategy Gains Strength with Additional Liquidity

Prenetics initiated a bitcoin treasury strategy in August with a “1 BTC per day” accumulation plan. As of October 27, the company holds approximately 275 BTC, worth around $31 million. The new funding boosts its liquidity to $131 million, supporting further expansion of its crypto treasury.

The offering includes Class A and B warrants priced with a 50% and 100% premium, respectively, above the $16.08 offering price. If fully exercised for cash, the warrants could provide an additional $168 million in gross proceeds. This would push total proceeds from the deal to $216 million, fueling further crypto asset acquisition.

The strategy has attracted significant backing from crypto and digital asset powerhouses like Kraken, Exodus, GPTX, and DL Holdings. Their participation highlights strategic alignment with Prenetics’ long-term plan to hold $1 billion in Bitcoin within five years. These partnerships may also unlock future synergies within digital finance and wellness ecosystems.

Strategic Shareholders Back Vision with Long-Term Commitments

Prominent names including Aryna Sabalenka, Adrian Cheng, and Johnny Han increased their holdings in the latest round. Their continued support underscores confidence in Prenetics’ vision for wellness and digital asset integration. The company also benefits from their strategic influence across Asia-Pacific’s business landscape.

The offering, led by Dominari Securities LLC, attracted a mix of institutional and high-profile individual participants. This capital injection sets the foundation for aggressive scaling of IM8 and Bitcoin reserves. Prenetics aims to reach $1 billion in revenue and an equivalent amount in BTC holdings within five years.

The deal is expected to close around October 28, subject to standard conditions. With a stronger capital base, Prenetics appears positioned to transform its business through focused execution. As the company narrows its priorities, both IM8 and its Bitcoin strategy are likely to drive future performance.